Your browser doesn't support javascript.
loading
GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis.
Skuladottir, Astros Th; Stefansdottir, Lilja; Halldorsson, Gisli H; Stefansson, Olafur A; Bjornsdottir, Anna; Jonsson, Palmi; Palmadottir, Vala; Thorgeirsson, Thorgeir E; Walters, G Bragi; Gisladottir, Rosa S; Bjornsdottir, Gyda; Jonsdottir, Gudrun A; Sulem, Patrick; Gudbjartsson, Daniel F; Knowlton, Kirk U; Jones, David A; Ottas, Aigar; Pedersen, Ole B; Didriksen, Maria; Brunak, Søren; Banasik, Karina; Hansen, Thomas Folkmann; Erikstrup, Christian; Haavik, Jan; Andreassen, Ole A; Rye, David; Igland, Jannicke; Ostrowski, Sisse Rye; Milani, Lili A; Nadauld, Lincoln D; Stefansson, Hreinn; Stefansson, Kari.
Affiliation
  • Skuladottir AT; deCODE genetics/Amgen Inc., Reykjavik, Iceland. astros.skuladottir@decode.is.
  • Stefansdottir L; Faculty of Medicine, University of Iceland, Reykjavik, Iceland. astros.skuladottir@decode.is.
  • Halldorsson GH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Stefansson OA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Bjornsdottir A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsson P; Heilsuklasinn Clinic, Reykjavik, Iceland.
  • Palmadottir V; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Thorgeirsson TE; Department of Geriatric Medicine, Landspitali University Hospital, Reykjavik, Iceland.
  • Walters GB; Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland.
  • Gisladottir RS; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Bjornsdottir G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsdottir GA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sulem P; Faculty of Icelandic and Comparative Cultural Studies, University of Iceland, Reykjavik, Iceland.
  • Gudbjartsson DF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Knowlton KU; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jones DA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Ottas A; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Pedersen OB; Intermountain Medical Center, Intermountain Heart Institute, Salt Lake City, USA.
  • Didriksen M; Precision Genomics, Intermountain Healthcare, Saint George, Utah, UK.
  • Brunak S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Hansen TF; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
  • Erikstrup C; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Haavik J; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Andreassen OA; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rye D; Danish Headache Center, Department of Neurology, Copenhagen University Hospital, Righospitalet-Glostrup, Copenhagen, Denmark.
  • Igland J; Department of Clinical Immunology, Aarhus University Hospital, Righospitalet, Copenhagen, Denmark.
  • Ostrowski SR; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Aarhus University, Aarhus, Denmark.
  • Nadauld LD; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Stefansson H; Bergen Center of Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
  • Stefansson K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Commun Biol ; 7(1): 504, 2024 Apr 26.
Article in En | MEDLINE | ID: mdl-38671141
ABSTRACT
Essential tremor (ET) is a prevalent neurological disorder with a largely unknown underlying biology. In this genome-wide association study meta-analysis, comprising 16,480 ET cases and 1,936,173 controls from seven datasets, we identify 12 sequence variants at 11 loci. Evaluating mRNA expression, splicing, plasma protein levels, and coding effects, we highlight seven putative causal genes at these loci, including CA3 and CPLX1. CA3 encodes Carbonic Anhydrase III and carbonic anhydrase inhibitors have been shown to decrease tremors. CPLX1, encoding Complexin-1, regulates neurotransmitter release. Through gene-set enrichment analysis, we identify a significant association with specific cell types, including dopaminergic and GABAergic neurons, as well as biological processes like Rho GTPase signaling. Genetic correlation analyses reveals a positive association between ET and Parkinson's disease, depression, and anxiety-related phenotypes. This research uncovers risk loci, enhancing our knowledge of the complex genetics of this common but poorly understood disorder, and highlights CA3 and CPLX1 as potential therapeutic targets.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Genetic Predisposition to Disease / Essential Tremor / Genome-Wide Association Study Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Genetic Predisposition to Disease / Essential Tremor / Genome-Wide Association Study Limits: Humans Language: En Year: 2024 Type: Article